Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Women with hair loss should be checked for PCOS, as it's often related and early diagnosis can help with treatment.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Most patients prefer clinics that play music during procedures.

Higher blood sugar levels may lead to more severe hair loss in women.

Low-dose spironolactone can be effective for treating hair loss in women.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Alopecia is a condition causing hair loss that can impact looks and mental health.

Patients were highly satisfied with shared medical appointments for hair loss treatment.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

Platelet-rich plasma may help with hair loss from androgenetic alopecia.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Patients with skin of color are more likely to use supplements for hair loss than Caucasian patients, but the effectiveness of these supplements is uncertain and they can be expensive.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Alternative medicine might help with hair loss.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.